User: Guest  Login
Title:

RIG-I activation is critical for responsiveness to checkpoint blockade.

Document type:
Journal Article
Author(s):
Heidegger, Simon; Wintges, Alexander; Stritzke, Florian; Bek, Sarah; Steiger, Katja; Koenig, Paul-Albert; Göttert, Sascha; Engleitner, Thomas; Öllinger, Rupert; Nedelko, Tatiana; Fischer, Julius C; Makarov, Vladimir; Winter, Christof; Rad, Roland; van den Brink, Marcel R M; Ruland, Jürgen; Bassermann, Florian; Chan, Timothy A; Haas, Tobias; Poeck, Hendrik
Abstract:
Achieving durable clinical responses to immune checkpoint inhibitors remains a challenge. Here, we demonstrate that immunotherapy with anti-CTLA-4 and its combination with anti-PD-1 rely on tumor cell-intrinsic activation of the cytosolic RNA receptor RIG-I. Mechanistically, tumor cell-intrinsic RIG-I signaling induced caspase-3-mediated tumor cell death, cross-presentation of tumor-associated antigen by CD103+ dendritic cells, subsequent expansion of tumor antigen-specific CD8+ T cells, and the...     »
Journal title abbreviation:
Sci Immunol
Year:
2019
Journal volume:
4
Journal issue:
39
Fulltext / DOI:
doi:10.1126/sciimmunol.aau8943
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/31519811
Print-ISSN:
2470-9468
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie); Institut für Allgemeine Pathologie und Pathologische Anatomie; Institut für Klinische Chemie und Pathobiochemie; Klinik und Poliklinik für RadioOnkologie und Strahlentherapie; Professur für Translationale gastroenterologische Onkologie (Prof. Rad)
 BibTeX